OPKO HEALTH INC. - COMMON STOCK

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results

30 апр 2025 15:05:00 Источник Nasdaq GlobeNewswire

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025

17 апр 2025 07:00:01 Источник Nasdaq GlobeNewswire

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

04 апр 2025 07:00:00 Источник Nasdaq GlobeNewswire

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

17 мар 2025 07:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

05 мар 2025 08:52:19 Источник NetDania Notify

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

04 мар 2025 10:11:28 Источник NetDania Notify

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

28 фев 2025 08:52:41 Источник NetDania Notify

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

27 фев 2025 15:10:15 Источник Nasdaq GlobeNewswire

OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025

13 фев 2025 15:05:00 Источник Nasdaq GlobeNewswire

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

09 янв 2025 10:45:00 Источник Nasdaq GlobeNewswire

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

07 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

12 дек 2024 10:21:35 Источник NetDania Notify

OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

20 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire

OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

07 ноя 2024 15:05:11 Источник Nasdaq GlobeNewswire

OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024

29 окт 2024 15:05:00 Источник Nasdaq GlobeNewswire

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

07 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire

OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development

23 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

17 сен 2024 10:54:13 Источник NetDania Notify

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

07 авг 2024 15:06:35 Источник Nasdaq GlobeNewswire

OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024

01 авг 2024 15:05:00 Источник Nasdaq GlobeNewswire